• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病相关精神病:当前的治疗选择及其对患者和照护者的影响。

Psychosis in Parkinson's Disease: Current Treatment Options and Impact on Patients and Caregivers.

机构信息

7547Saint Louis University School of Medicine, Saint Louis, MO, USA.

Department of Psychiatry and Behavioral Neuroscience, 7547Saint Louis University School of Medicine, MO, USA.

出版信息

J Geriatr Psychiatry Neurol. 2021 Jul;34(4):274-279. doi: 10.1177/08919887211018280.

DOI:10.1177/08919887211018280
PMID:34219522
Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disease seen in older adults after Alzheimer's disease, with increasing prevalence worldwide. Parkinson's disease psychosis (PDP) is a common, non-motor feature of PD, which increases caregiver stress and is a risk-factor for nursing home placement. In this paper we review PDP epidemiology, features, diagnosis, and treatment. PDP most often presents with sequential development of minor and then increasingly complex visual hallucinations mediated by dopaminergic-serotonergic interactions activating the mesolimbic pathway, with contributions from other structures and neurotransmitters. Appropriate evaluation of differential diagnoses for psychosis is vital before diagnosing PDP. Initial treatment should involve non-pharmacologic approaches. If these are unsuccessful and PDP symptoms significantly impact the patient's and or their caregivers' quality of life and functions, then pharmacotherapy is indicated. Pimavanserin is a recently FDA-approved pharmacologic treatment for PDP with a better profile of balanced effectiveness and safety compared to previous use of atypical antipsychotics. Early diagnosis and safer, more effective treatments for PDP should help reduce caregiver burden and enable caregivers to continue to provide care at home versus institutionalization.

摘要

帕金森病(PD)是仅次于阿尔茨海默病(AD)的第二大常见于老年人的神经退行性疾病,在全球范围内的患病率不断增加。帕金森病精神病(PDP)是 PD 的一种常见非运动特征,它会增加护理人员的压力,也是入住养老院的一个风险因素。在本文中,我们回顾了 PDP 的流行病学、特征、诊断和治疗。PDP 最常表现为多巴胺-5-羟色胺相互作用介导的轻微且逐渐复杂的视觉幻觉的顺序发展,激活中脑边缘通路,其他结构和神经递质也有贡献。在诊断 PDP 之前,对精神病的鉴别诊断进行适当的评估至关重要。初始治疗应包括非药物治疗方法。如果这些方法不成功,并且 PDP 症状显著影响患者及其护理人员的生活质量和功能,那么就需要药物治疗。Pimavanserin 是最近获得美国食品和药物管理局(FDA)批准的用于治疗 PDP 的药物,与之前使用的非典型抗精神病药物相比,其在疗效和安全性方面具有更好的平衡特征。早期诊断和更安全、更有效的 PDP 治疗方法应有助于减轻护理人员的负担,并使护理人员能够继续在家中而不是在机构中提供护理。

相似文献

1
Psychosis in Parkinson's Disease: Current Treatment Options and Impact on Patients and Caregivers.帕金森病相关精神病:当前的治疗选择及其对患者和照护者的影响。
J Geriatr Psychiatry Neurol. 2021 Jul;34(4):274-279. doi: 10.1177/08919887211018280.
2
Pimavanserin, a novel antipsychotic for management of Parkinson's disease psychosis.匹莫范色林,一种用于治疗帕金森病精神病的新型抗精神病药物。
Expert Rev Clin Pharmacol. 2017 Nov;10(11):1161-1168. doi: 10.1080/17512433.2017.1369405. Epub 2017 Oct 17.
3
Parkinson's disease and Parkinson's disease psychosis: a perspective on the challenges, treatments, and economic burden.帕金森病与帕金森病性精神病:关于挑战、治疗及经济负担的观点
Am J Manag Care. 2017 Apr;23(5 Suppl):S83-S92.
4
Hallucinations and delusions associated with Parkinson's disease psychosis: safety of current treatments and future directions.与帕金森病精神病相关的幻觉和妄想:当前治疗方法的安全性及未来方向
Expert Opin Drug Saf. 2022 Jul;21(7):873-879. doi: 10.1080/14740338.2022.2069240. Epub 2022 May 3.
5
Psychosis in Parkinson's Disease: Looking Beyond Dopaminergic Treatments.帕金森病中的精神病:超越多巴胺治疗方法。
Curr Pharm Des. 2022;28(33):2725-2741. doi: 10.2174/1381612828666220428102802.
6
Changing the treatment paradigm for Parkinson's disease psychosis with pimavanserin.用 pimavanserin 改变帕金森病精神病的治疗模式。
Expert Rev Clin Pharmacol. 2019 Jul;12(7):681-691. doi: 10.1080/17512433.2019.1623669. Epub 2019 Jun 13.
7
On the Optimal Diagnosis and the Evolving Role of Pimavanserin in Parkinson's Disease Psychosis.关于帕金森病精神病的最佳诊断和比哌立登作用的演变。
CNS Drugs. 2024 May;38(5):333-347. doi: 10.1007/s40263-024-01084-1. Epub 2024 Apr 8.
8
Treating Hallucinations and Delusions Associated With Parkinson's Disease Psychosis.治疗帕金森病精神病相关的幻觉和妄想。
Curr Psychiatry Rep. 2018 Jan 27;20(1):3. doi: 10.1007/s11920-018-0869-z.
9
On the discovery and development of pimavanserin: a novel drug candidate for Parkinson's psychosis.关于匹莫范色林的发现与开发:一种用于帕金森病精神病的新型候选药物。
Neurochem Res. 2014 Oct;39(10):2008-17. doi: 10.1007/s11064-014-1293-3. Epub 2014 Mar 30.
10
Atypical antipsychotic therapy in Parkinson's disease psychosis: A retrospective study.帕金森病精神病中的非典型抗精神病药物治疗:一项回顾性研究。
Brain Behav. 2017 Apr 14;7(6):e00639. doi: 10.1002/brb3.639. eCollection 2017 Jun.

引用本文的文献

1
Structural MRI study of Pareidolia and Visual Hallucinations in Drug-Naïve Parkinson's disease.初发帕金森病中幻想性错觉与视幻觉的结构磁共振成像研究
Sci Rep. 2024 Dec 28;14(1):31293. doi: 10.1038/s41598-024-82707-x.
2
The effects of chemogenetic targeting of serotonin-projecting pathways on L-DOPA-induced dyskinesia and psychosis in a bilateral rat model of Parkinson's disease.在帕金森病双侧大鼠模型中,血清素投射通路的化学遗传靶向对左旋多巴诱导的运动障碍和精神病的影响。
Front Neural Circuits. 2024 Nov 14;18:1463941. doi: 10.3389/fncir.2024.1463941. eCollection 2024.
3
On the Optimal Diagnosis and the Evolving Role of Pimavanserin in Parkinson's Disease Psychosis.
关于帕金森病精神病的最佳诊断和比哌立登作用的演变。
CNS Drugs. 2024 May;38(5):333-347. doi: 10.1007/s40263-024-01084-1. Epub 2024 Apr 8.
4
Parkinson's disease updates: Addressing the pathophysiology, risk factors, genetics, diagnosis, along with the medical and surgical treatment.帕金森病最新进展:探讨其病理生理学、危险因素、遗传学、诊断以及药物和手术治疗。
Ann Med Surg (Lond). 2023 Aug 8;85(10):4887-4902. doi: 10.1097/MS9.0000000000001142. eCollection 2023 Oct.
5
Palliative Care of End Stage Parkinsonism: An Overview Including the Five Pillars Framework.晚期帕金森病的姑息治疗:概述及五大支柱框架
Mov Disord Clin Pract. 2022 Nov 30;10(Suppl 2):S63-S67. doi: 10.1002/mdc3.13620. eCollection 2023 Aug.
6
Neurological update: non-motor symptoms in atypical parkinsonian syndromes.神经科最新进展:非运动症状在非典型帕金森综合征中的表现。
J Neurol. 2023 Sep;270(9):4558-4578. doi: 10.1007/s00415-023-11807-x. Epub 2023 Jun 15.
7
Tinetti balance performance is associated with mortality in older adults with late-onset Parkinson's disease: a longitudinal study.Tinetti 平衡表现与老年晚发性帕金森病患者的死亡率相关:一项纵向研究。
BMC Geriatr. 2023 Jan 30;23(1):54. doi: 10.1186/s12877-023-03776-7.
8
Pimavanserin and Parkinson's Disease Psychosis: A Narrative Review.匹莫范色林与帕金森病精神病:一项叙述性综述。
Brain Sci. 2022 Sep 23;12(10):1286. doi: 10.3390/brainsci12101286.
9
Management of Psychiatric Disorders in Patients with Parkinson's Diseases.帕金森病患者精神障碍的管理
Indian J Psychiatry. 2022 Mar;64(Suppl 2):S330-S343. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_29_22. Epub 2022 Mar 23.